AHR competition with HIF-1α for binding to ARNT in pro-inflammatory and anaerobic responses, together with AHR antagonism of TGF-β1 cell signaling in fibrogenesis, support potential targeting of AHR to slow CKD progression. Here, ARNT is linked to chronic kidney disease.